Rolf Lood


If you made any changes in Pure these will be visible here soon.

Personal profile


The area of Experimental Infection Medicine encompasses beneficial and detrimental aspects of microbes:

  • Benevolent bacteria

We are all colonized by a plethora of bacteria, but remain healthy. Can specific beneficial bacteria contribute to health? We are investigating the impact of bacteria (probiotics) and bacterial proteins in maintaining health.

  • Killing of bacteria

The Lood lab uses novel experimental means to combat infections which include predatory bacteria, bacteriophages and phage enzymes.

  •  Antibiotic resistance

We are investigating the biology behind, and means to limit the spread of mobile genetic elements (e.g. phage), which can generate antibiotic resistant bacterial infections.

The lab focuses on translational research, collaborating with medical doctors, chemists, engineers, mathematicians, genetics, biotechnologists, biomedicine professionals, evolutionary biologists, and interact with several industrial partners; working with both basic and applied research.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 15 - Life on Land

UKÄ subject classification

  • Infectious Medicine
  • Medical Biotechnology
  • Dermatology and Venereal Diseases
  • Microbiology in the medical area
  • Microbiology
  • Biochemistry and Molecular Biology
  • Genetics


Dive into the research topics where Rolf Lood is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or